These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 9712018)

  • 1. Selective deamidation by tissue transglutaminase strongly enhances gliadin-specific T cell reactivity.
    van de Wal Y; Kooy Y; van Veelen P; Peña S; Mearin L; Papadopoulos G; Koning F
    J Immunol; 1998 Aug; 161(4):1585-8. PubMed ID: 9712018
    [TBL] [Abstract][Full Text] [Related]  

  • 2. T cells from celiac disease lesions recognize gliadin epitopes deamidated in situ by endogenous tissue transglutaminase.
    Molberg O; McAdam S; Lundin KE; Kristiansen C; Arentz-Hansen H; Kett K; Sollid LM
    Eur J Immunol; 2001 May; 31(5):1317-23. PubMed ID: 11465088
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A quantitative analysis of transglutaminase 2-mediated deamidation of gluten peptides: implications for the T-cell response in celiac disease.
    Dørum S; Qiao SW; Sollid LM; Fleckenstein B
    J Proteome Res; 2009 Apr; 8(4):1748-55. PubMed ID: 19239248
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The intestinal T cell response to alpha-gliadin in adult celiac disease is focused on a single deamidated glutamine targeted by tissue transglutaminase.
    Arentz-Hansen H; Körner R; Molberg O; Quarsten H; Vader W; Kooy YM; Lundin KE; Koning F; Roepstorff P; Sollid LM; McAdam SN
    J Exp Med; 2000 Feb; 191(4):603-12. PubMed ID: 10684852
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cross linking to tissue transglutaminase and collagen favours gliadin toxicity in coeliac disease.
    Dieterich W; Esslinger B; Trapp D; Hahn E; Huff T; Seilmeier W; Wieser H; Schuppan D
    Gut; 2006 Apr; 55(4):478-84. PubMed ID: 16188922
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monitoring of in vitro deamidation of gliadin peptic fragment by mass spectrometry may reflect one of the molecular mechanisms taking place in celiac disease development.
    Novák P; Man P; Tucková L; Tlaskalová-Hogenová H; Bezouska K; Havlícek V
    J Mass Spectrom; 2002 May; 37(5):507-11. PubMed ID: 12112756
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo antigen challenge in celiac disease identifies a single transglutaminase-modified peptide as the dominant A-gliadin T-cell epitope.
    Anderson RP; Degano P; Godkin AJ; Jewell DP; Hill AV
    Nat Med; 2000 Mar; 6(3):337-42. PubMed ID: 10700238
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tissue transglutaminase--the key player in celiac disease: a review.
    Reif S; Lerner A
    Autoimmun Rev; 2004 Jan; 3(1):40-5. PubMed ID: 14871648
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence of a selective epitope loss of anti-transglutaminase immunoreactivity in gluten-free diet celiac sera: a new tool to distinguish disease-specific immunoreactivities.
    Tiberti C; Bonamico M; Dotta F; Verrienti A; Di Tola M; Liu E; Ferri M; Nenna R; Picarelli A; Eisenbarth GS
    Clin Immunol; 2006 Oct; 121(1):40-6. PubMed ID: 16798097
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blocking peptides decrease tissue transglutaminase processing of gliadin in vitro.
    Hoffmann K; Alminger M; Andlid T; Chen T; Olsson O; Sandberg AS
    J Agric Food Chem; 2009 Nov; 57(21):10150-5. PubMed ID: 19813732
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transamidation of wheat flour inhibits the response to gliadin of intestinal T cells in celiac disease.
    Gianfrani C; Siciliano RA; Facchiano AM; Camarca A; Mazzeo MF; Costantini S; Salvati VM; Maurano F; Mazzarella G; Iaquinto G; Bergamo P; Rossi M
    Gastroenterology; 2007 Sep; 133(3):780-9. PubMed ID: 17678925
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unexpected role of surface transglutaminase type II in celiac disease.
    Maiuri L; Ciacci C; Ricciardelli I; Vacca L; Raia V; Rispo A; Griffin M; Issekutz T; Quaratino S; Londei M
    Gastroenterology; 2005 Nov; 129(5):1400-13. PubMed ID: 16285941
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunogenic peptides can be detected in whole gluten by transamidating highly susceptible glutamine residues: implication in the search for gluten-free cereals.
    Mamone G; Camarca A; Fierro O; Sidney J; Mazzarella G; Addeo F; Auricchio S; Troncone R; Sette A; Gianfrani C
    J Agric Food Chem; 2013 Jan; 61(3):747-54. PubMed ID: 23244345
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antagonist peptides of the gliadin T-cell stimulatory sequences: a therapeutic strategy for celiac disease.
    Silano M; Vincentini O; Iapello A; Mancini E; De Vincenzi M
    J Clin Gastroenterol; 2008 Sep; 42 Suppl 3 Pt 2():S191-2. PubMed ID: 18685513
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deamidation and cross-linking of gliadin peptides by transglutaminases and the relation to celiac disease.
    Skovbjerg H; Koch C; Anthonsen D; Sjöström H
    Biochim Biophys Acta; 2004 Nov; 1690(3):220-30. PubMed ID: 15511629
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Natural variation in toxicity of wheat: potential for selection of nontoxic varieties for celiac disease patients.
    Spaenij-Dekking L; Kooy-Winkelaar Y; van Veelen P; Drijfhout JW; Jonker H; van Soest L; Smulders MJ; Bosch D; Gilissen LJ; Koning F
    Gastroenterology; 2005 Sep; 129(3):797-806. PubMed ID: 16143119
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression and enzymatic activity of small intestinal tissue transglutaminase in celiac disease.
    Esposito C; Paparo F; Caputo I; Porta R; Salvati VM; Mazzarella G; Auricchio S; Troncone R
    Am J Gastroenterol; 2003 Aug; 98(8):1813-20. PubMed ID: 12907337
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antigen presentation to celiac lesion-derived T cells of a 33-mer gliadin peptide naturally formed by gastrointestinal digestion.
    Qiao SW; Bergseng E; Molberg Ø; Xia J; Fleckenstein B; Khosla C; Sollid LM
    J Immunol; 2004 Aug; 173(3):1757-62. PubMed ID: 15265905
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Resistance to celiac disease in humanized HLA-DR3-DQ2-transgenic mice expressing specific anti-gliadin CD4+ T cells.
    de Kauwe AL; Chen Z; Anderson RP; Keech CL; Price JD; Wijburg O; Jackson DC; Ladhams J; Allison J; McCluskey J
    J Immunol; 2009 Jun; 182(12):7440-50. PubMed ID: 19494267
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tissue transglutaminase selectively modifies gliadin peptides that are recognized by gut-derived T cells in celiac disease.
    Molberg O; Mcadam SN; Körner R; Quarsten H; Kristiansen C; Madsen L; Fugger L; Scott H; Norén O; Roepstorff P; Lundin KE; Sjöström H; Sollid LM
    Nat Med; 1998 Jun; 4(6):713-7. PubMed ID: 9623982
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.